Literature DB >> 7923580

Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cancer cell lines.

E Aizu-Yokota1, K Ichinoseki, Y Sato.   

Abstract

Effects of estrogens on the cytoplasmic microtubule network were examined by the indirect immunofluorescence method using anti-beta-tubulin antibody. Estradiol, a naturally occurring estrogen, decreased the amount of cytoplasmic microtubule fibers during interphase in the human breast cancer cell lines MCF-7 and MDA-MB-231. Since MDA-MB-231 is an estrogen receptor-negative cell line, estradiol-induced microtubule disruption seems to be independent of estradiol binding to receptors. The effective concentration of estradiol required for induction of microtubule disruption in 50% of the cells (EC50) was 81 microM for MCF-7 cells and 82 microM for MDA-MB-231 cells. A synthetic estrogen, diethylstilbestrol, also induced a decrease in microtubule fibers, with an EC50 value of 48 microM for MCF-7 cells and 50 microM for MDA-MB-231 cells. When estrogen-treated and microtubule-depolymerized cells were washed and the medium was replaced with fresh, intracellular microtubule networks reappeared within 3 h. When MCF-7 cells were cultured for 4 days with estradiol (50 microM), cell growth was completely inhibited. However, estrone affected the microtubule network and cell proliferation only slightly. These results suggest that estradiol-induced microtubule disruption is closely related to its inhibitory effect on cell growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923580     DOI: 10.1093/carcin/15.9.1875

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  p150/glued modifies nuclear estrogen receptor function.

Authors:  Soo Jung Lee; Christina Chae; Michael M Wang
Journal:  Mol Endocrinol       Date:  2009-02-19

2.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms.

Authors:  Nicole C Kleinstreuer; Jian Yang; Ellen L Berg; Thomas B Knudsen; Ann M Richard; Matthew T Martin; David M Reif; Richard S Judson; Mark Polokoff; David J Dix; Robert J Kavlock; Keith A Houck
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

3.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

4.  Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects.

Authors:  Yama A Abassi; Biao Xi; Wenfu Zhang; Peifang Ye; Shelli L Kirstein; Michelle R Gaylord; Stuart C Feinstein; Xiaobo Wang; Xiao Xu
Journal:  Chem Biol       Date:  2009-07-31

5.  The effects of acute 17beta-estradiol treatment on gene expression in the young female mouse hippocampus.

Authors:  Angela S Pechenino; Karyn M Frick
Journal:  Neurobiol Learn Mem       Date:  2008-11-08       Impact factor: 2.877

6.  17Alpha-estradiol arrests cell cycle progression at G2/M and induces apoptotic cell death in human acute leukemia Jurkat T cells.

Authors:  Do Youn Jun; Hae Sun Park; Jun Seok Kim; Jong Sik Kim; Wan Park; Bang Ho Song; Hee-Sook Kim; Dennis Taub; Young Ho Kim
Journal:  Toxicol Appl Pharmacol       Date:  2008-06-04       Impact factor: 4.219

Review 7.  Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals.

Authors:  T Tsutsui; J C Barrett
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.

Authors:  H Koike; K Ito; Y Takezawa; T Oyama; H Yamanaka; K Suzuki
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

9.  High content imaging quantification of multiple in vitro human neurogenesis events after neurotoxin exposure.

Authors:  Xian Wu; Anirban Majumder; Robin Webb; Steven L Stice
Journal:  BMC Pharmacol Toxicol       Date:  2016-12-01       Impact factor: 2.483

10.  Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification.

Authors:  Jung-Hyun Cho; Ho-Young Chun; Jung Suk Lee; Jee-Hyun Lee; Kyu Jin Cheong; Youn-Sang Jung; Tae-Gyun Woo; Min-Ho Yoon; Ah-Young Oh; So-Mi Kang; Chunghui Lee; Hokeun Sun; Jihwan Hwang; Gyu-Yong Song; Bum-Joon Park
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.